Quality of Life in Japanese Patients with Dysmenorrhea or Endometriosis-Associated Pelvic Pain Treated with Extended Regimen Ethinylestradiol/Drospirenone in a Real-World Setting: A Prospective Observational Study
Introduction Dysmenorrhea and endometriosis are common gynecologic disorders among women of reproductive age that significantly impact health-related quality of life (HRQL) as well as productivity. Although there are treatment options listed in Japanese guidelines, a gap remains in unmet medical nee...
Saved in:
| Published in: | Advances in therapy Vol. 39; no. 11; pp. 5087 - 5104 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Cheshire
Springer Healthcare
01.11.2022
|
| Subjects: | |
| ISSN: | 0741-238X, 1865-8652, 1865-8652 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Introduction
Dysmenorrhea and endometriosis are common gynecologic disorders among women of reproductive age that significantly impact health-related quality of life (HRQL) as well as productivity. Although there are treatment options listed in Japanese guidelines, a gap remains in unmet medical needs for maximizing treatment outcome. The extended regimen of ethinylestradiol and drospirenone (EE/DRSP) (taken daily for up to 120 consecutive days) has been available in Japan for treating dysmenorrhea and/or endometriosis-associated pain since 2016. Yet, the effectiveness of its usage on HRQL has not been investigated elsewhere to date. Therefore, in this study, we aim to observe changes in HRQL of Japanese women treated with an extended regimen of EE/DRSP for dysmenorrhea and/or endometriosis-associated pain.
Methods
As part of a 2-year post-marketing surveillance study, women with dysmenorrhea or endometriosis-associated pelvic pain were prescribed extended EE/DRSP during routine clinical practice. Data were collected 1 month before and 3 and 6 months after initiating treatment. Primary outcomes were the Menstrual Distress Questionnaire (MDQ) (before, during, and after menstruation) in patients with dysmenorrhea, and the Endometriosis Impact Scale (EIS) and European Quality of Life 5-dimensions 5-level instrument (EQ-5D-5L) in patients with endometriosis.
Results
The study cohort included 315 patients (mean age 28.9 years) with dysmenorrhea and 262 patients (mean age 31.3 years) with endometriosis. Mean MDQ total scores before and during menstruation decreased significantly after 6 months with extended EE/DRSP; there was no improvement in after-menstruation MDQ score. Mean EIS domain scores improved significantly by 6 months, with improvement in most EIS individual item scores. Mean EQ-5D-5L scores increased slightly during 6 months of treatment.
Conclusions
Extended EE/DRSP treatment improved HRQL outcomes in Japanese women with dysmenorrhea or endometriosis-associated pelvic pain.
Trial Registration
Registered at ClinicalTrials.gov (NCT03126747) on June 2017. |
|---|---|
| AbstractList | Dysmenorrhea and endometriosis are common gynecologic disorders among women of reproductive age that significantly impact health-related quality of life (HRQL) as well as productivity. Although there are treatment options listed in Japanese guidelines, a gap remains in unmet medical needs for maximizing treatment outcome. The extended regimen of ethinylestradiol and drospirenone (EE/DRSP) (taken daily for up to 120 consecutive days) has been available in Japan for treating dysmenorrhea and/or endometriosis-associated pain since 2016. Yet, the effectiveness of its usage on HRQL has not been investigated elsewhere to date. Therefore, in this study, we aim to observe changes in HRQL of Japanese women treated with an extended regimen of EE/DRSP for dysmenorrhea and/or endometriosis-associated pain.
As part of a 2-year post-marketing surveillance study, women with dysmenorrhea or endometriosis-associated pelvic pain were prescribed extended EE/DRSP during routine clinical practice. Data were collected 1 month before and 3 and 6 months after initiating treatment. Primary outcomes were the Menstrual Distress Questionnaire (MDQ) (before, during, and after menstruation) in patients with dysmenorrhea, and the Endometriosis Impact Scale (EIS) and European Quality of Life 5-dimensions 5-level instrument (EQ-5D-5L) in patients with endometriosis.
The study cohort included 315 patients (mean age 28.9 years) with dysmenorrhea and 262 patients (mean age 31.3 years) with endometriosis. Mean MDQ total scores before and during menstruation decreased significantly after 6 months with extended EE/DRSP; there was no improvement in after-menstruation MDQ score. Mean EIS domain scores improved significantly by 6 months, with improvement in most EIS individual item scores. Mean EQ-5D-5L scores increased slightly during 6 months of treatment.
Extended EE/DRSP treatment improved HRQL outcomes in Japanese women with dysmenorrhea or endometriosis-associated pelvic pain.
Registered at ClinicalTrials.gov (NCT03126747) on June 2017. Introduction Dysmenorrhea and endometriosis are common gynecologic disorders among women of reproductive age that significantly impact health-related quality of life (HRQL) as well as productivity. Although there are treatment options listed in Japanese guidelines, a gap remains in unmet medical needs for maximizing treatment outcome. The extended regimen of ethinylestradiol and drospirenone (EE/DRSP) (taken daily for up to 120 consecutive days) has been available in Japan for treating dysmenorrhea and/or endometriosis-associated pain since 2016. Yet, the effectiveness of its usage on HRQL has not been investigated elsewhere to date. Therefore, in this study, we aim to observe changes in HRQL of Japanese women treated with an extended regimen of EE/DRSP for dysmenorrhea and/or endometriosis-associated pain. Methods As part of a 2-year post-marketing surveillance study, women with dysmenorrhea or endometriosis-associated pelvic pain were prescribed extended EE/DRSP during routine clinical practice. Data were collected 1 month before and 3 and 6 months after initiating treatment. Primary outcomes were the Menstrual Distress Questionnaire (MDQ) (before, during, and after menstruation) in patients with dysmenorrhea, and the Endometriosis Impact Scale (EIS) and European Quality of Life 5-dimensions 5-level instrument (EQ-5D-5L) in patients with endometriosis. Results The study cohort included 315 patients (mean age 28.9 years) with dysmenorrhea and 262 patients (mean age 31.3 years) with endometriosis. Mean MDQ total scores before and during menstruation decreased significantly after 6 months with extended EE/DRSP; there was no improvement in after-menstruation MDQ score. Mean EIS domain scores improved significantly by 6 months, with improvement in most EIS individual item scores. Mean EQ-5D-5L scores increased slightly during 6 months of treatment. Conclusions Extended EE/DRSP treatment improved HRQL outcomes in Japanese women with dysmenorrhea or endometriosis-associated pelvic pain. Trial Registration Registered at ClinicalTrials.gov (NCT03126747) on June 2017. Dysmenorrhea and endometriosis are common gynecologic disorders among women of reproductive age that significantly impact health-related quality of life (HRQL) as well as productivity. Although there are treatment options listed in Japanese guidelines, a gap remains in unmet medical needs for maximizing treatment outcome. The extended regimen of ethinylestradiol and drospirenone (EE/DRSP) (taken daily for up to 120 consecutive days) has been available in Japan for treating dysmenorrhea and/or endometriosis-associated pain since 2016. Yet, the effectiveness of its usage on HRQL has not been investigated elsewhere to date. Therefore, in this study, we aim to observe changes in HRQL of Japanese women treated with an extended regimen of EE/DRSP for dysmenorrhea and/or endometriosis-associated pain.INTRODUCTIONDysmenorrhea and endometriosis are common gynecologic disorders among women of reproductive age that significantly impact health-related quality of life (HRQL) as well as productivity. Although there are treatment options listed in Japanese guidelines, a gap remains in unmet medical needs for maximizing treatment outcome. The extended regimen of ethinylestradiol and drospirenone (EE/DRSP) (taken daily for up to 120 consecutive days) has been available in Japan for treating dysmenorrhea and/or endometriosis-associated pain since 2016. Yet, the effectiveness of its usage on HRQL has not been investigated elsewhere to date. Therefore, in this study, we aim to observe changes in HRQL of Japanese women treated with an extended regimen of EE/DRSP for dysmenorrhea and/or endometriosis-associated pain.As part of a 2-year post-marketing surveillance study, women with dysmenorrhea or endometriosis-associated pelvic pain were prescribed extended EE/DRSP during routine clinical practice. Data were collected 1 month before and 3 and 6 months after initiating treatment. Primary outcomes were the Menstrual Distress Questionnaire (MDQ) (before, during, and after menstruation) in patients with dysmenorrhea, and the Endometriosis Impact Scale (EIS) and European Quality of Life 5-dimensions 5-level instrument (EQ-5D-5L) in patients with endometriosis.METHODSAs part of a 2-year post-marketing surveillance study, women with dysmenorrhea or endometriosis-associated pelvic pain were prescribed extended EE/DRSP during routine clinical practice. Data were collected 1 month before and 3 and 6 months after initiating treatment. Primary outcomes were the Menstrual Distress Questionnaire (MDQ) (before, during, and after menstruation) in patients with dysmenorrhea, and the Endometriosis Impact Scale (EIS) and European Quality of Life 5-dimensions 5-level instrument (EQ-5D-5L) in patients with endometriosis.The study cohort included 315 patients (mean age 28.9 years) with dysmenorrhea and 262 patients (mean age 31.3 years) with endometriosis. Mean MDQ total scores before and during menstruation decreased significantly after 6 months with extended EE/DRSP; there was no improvement in after-menstruation MDQ score. Mean EIS domain scores improved significantly by 6 months, with improvement in most EIS individual item scores. Mean EQ-5D-5L scores increased slightly during 6 months of treatment.RESULTSThe study cohort included 315 patients (mean age 28.9 years) with dysmenorrhea and 262 patients (mean age 31.3 years) with endometriosis. Mean MDQ total scores before and during menstruation decreased significantly after 6 months with extended EE/DRSP; there was no improvement in after-menstruation MDQ score. Mean EIS domain scores improved significantly by 6 months, with improvement in most EIS individual item scores. Mean EQ-5D-5L scores increased slightly during 6 months of treatment.Extended EE/DRSP treatment improved HRQL outcomes in Japanese women with dysmenorrhea or endometriosis-associated pelvic pain.CONCLUSIONSExtended EE/DRSP treatment improved HRQL outcomes in Japanese women with dysmenorrhea or endometriosis-associated pelvic pain.Registered at ClinicalTrials.gov (NCT03126747) on June 2017.TRIAL REGISTRATIONRegistered at ClinicalTrials.gov (NCT03126747) on June 2017. |
| Author | Suzukamo, Yoshimi Yoshihara, Keisuke Yoshino, Osamu Takahashi, Noriko |
| Author_xml | – sequence: 1 givenname: Osamu orcidid: 0000-0001-6942-3018 surname: Yoshino fullname: Yoshino, Osamu email: oyoshino@yamanashi.ac.jp organization: Department of Obstetrics and Gynecology, University of Yamanashi – sequence: 2 givenname: Yoshimi surname: Suzukamo fullname: Suzukamo, Yoshimi organization: Department of Physical Medicine and Rehabilitation, Tohoku University Graduate School of Medicine – sequence: 3 givenname: Keisuke surname: Yoshihara fullname: Yoshihara, Keisuke organization: Bayer Yakuhin, Ltd – sequence: 4 givenname: Noriko surname: Takahashi fullname: Takahashi, Noriko organization: Bayer Yakuhin, Ltd |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36053449$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9Uk1vEzEQtVARTQt_gAPykctSf-wnB6SoDQUUqYEWwc3yrmcTV44dbG_o_lD-D07SIuDQw9iy_d6b8cw7QUfWWUDoJSVvKCHVWaCMsyIjjKXghGb8CZrQuiyyFOwITUiV04zx-vsxOgnhlhBGqqJ-ho55SQqe580E_fo8SKPjiF2P57oHrC3-JDfSQgC8kFGDjQH_1HGFL8awBuu8X4HEzuOZVW4N0WsXdMimIbhOywgKL8BsdZfYSevGw_5urzC7i2BVOn2BpU5aeBZX2o4GQvRSaWfOLrwLG-1h99NdKTJBpcm-OW8UvoYYtV2-xVO82OGgi3oL-KoN4LepVGelwddxUONz9LSXJsCL-_0UfX0_uzn_kM2vLj-eT-dZl-dlzCgrS654A2Xd857RVkKfK6Btx6nipK8q0rZ13tSyYUUL0Dayz6Hs6nq3KuCn6N1BdzO0a1BdapaXRmy8Xks_Cie1-PfF6pVYuq1oClbwJk8Cr-8FvPsxpD6ItQ4dGJMG4IYgWEWaKueE1wn66u9cf5I8zDIB6gOgS80JHnrR6bhvS0qtjaBE7GwjDrYRyTZibxvBE5X9R31Qf5TED6SQwHYJXty6wacZhMdYvwHs7twP |
| CitedBy_id | crossref_primary_10_1155_jonm_1968522 crossref_primary_10_3390_endocrines5010003 crossref_primary_10_1186_s12978_024_01739_8 crossref_primary_10_3389_fmed_2022_938606 |
| Cites_doi | 10.1016/j.fertnstert.2007.03.069 10.1097/00006842-196811000-00006 10.1530/REP-16-0052 10.1056/NEJMra1810764 10.1111/jog.13831 10.3109/03009730903457218 10.2147/IJWH.S134576 10.3389/fpsyt.2021.686514 10.3111/13696998.2013.830974 10.1097/AOG.0000000000002978 10.1007/s11136-011-9903-x 10.1016/j.jpag.2012.12.001 10.1186/s12905-021-01385-3 10.1016/j.fertnstert.2021.07.1194 10.1159/000452660 10.1186/s12978-018-0540-5 10.1080/03007995.2022.2031144 10.1001/archpedi.154.12.1226 10.1016/0029-7844(95)00360-6 10.1093/humupd/dmt016 10.2147/IJWH.S242864 10.3390/ijerph182010602 10.1016/j.jsxm.2021.11.015 10.1016/j.fertnstert.2017.07.1165 10.1007/s13669-017-0187-1 10.1016/j.ijgo.2004.09.004 10.2147/IJWH.S238460 10.1186/s41687-020-0177-3 10.1016/j.fertnstert.2011.02.045 10.1055/s-0031-1299596 10.1097/01.MLR.0000062554.74615.4C 10.1056/NEJMra0804690 10.1016/S0889-8545(05)70302-8 10.1016/j.ejogrb.2021.10.029 10.1038/s41574-019-0245-z |
| ContentType | Journal Article |
| Copyright | The Author(s) 2022 2022. The Author(s). |
| Copyright_xml | – notice: The Author(s) 2022 – notice: 2022. The Author(s). |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| DOI | 10.1007/s12325-022-02301-3 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1865-8652 |
| EndPage | 5104 |
| ExternalDocumentID | PMC9525394 36053449 10_1007_s12325_022_02301_3 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Observational Study |
| GeographicLocations | Japan |
| GeographicLocations_xml | – name: Japan |
| GroupedDBID | --- -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 23M 2J2 2JN 2JY 2KG 2KM 2VQ 30V 4.4 406 408 40D 40E 53G 5GY 5VS 67Z 6NX 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAIAL AAIKX AAJKR AANXM AANZL AARHV AARTL AASML AATNV AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABFTV ABHLI ABJNI ABJOX ABKCH ABMNI ABNWP ABPLI ABQBU ABTKH ABTMW ABXPI ACAOD ACCOQ ACDTI ACGFS ACHXU ACKNC ACMLO ACOKC ACPIV ACSNA ACZOJ ADFZG ADHHG ADHIR ADINQ ADKPE ADRFC ADURQ AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFALF AFBBN AFLOW AFWTZ AFZKB AGAYW AGDGC AGJBK AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AJBLW AJRNO ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR ANMIH ARMRJ AWSVR AXYYD B-. BA0 BGNMA C6C CAG COF CS3 CSCUP DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FERAY FFXSO FIGPU FLLZZ FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 H13 HF~ HG5 HG6 HMJXF HRMNR HZ~ IWAJR IXC IXD I~X I~Z J-C JBSCW JZLTJ KOV KPH LLZTM M4Y MA- MK0 NQJWS NU0 O9- O93 O9I OVD P2P P9S PF0 QOR QOS R89 R9I ROL RPX RSV S16 S1Z S27 S37 S3B SAP SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPKJE SRMVM SSLCW SV3 SZ9 SZN T13 TEORI TSG TSK TT1 TUC U2A U9L UG4 UTJUX UZXMN VC2 VDBLX VFIZW W48 WK8 Z45 Z7U Z7V Z81 Z82 Z83 Z84 Z87 ZMTXR ~A9 ~JE AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC AEZWR AFDZB AFHIU AFOHR AHWEU AIXLP ATHPR AYFIA CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c446t-12663d39e68f3f21baef4de1bc31d30f770bb8498a925beeb9af4e6c884e6cde3 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 4 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000849172800003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0741-238X 1865-8652 |
| IngestDate | Thu Aug 21 18:39:26 EDT 2025 Thu Oct 02 05:18:28 EDT 2025 Wed Feb 19 02:23:47 EST 2025 Tue Nov 18 21:58:02 EST 2025 Sat Nov 29 02:31:40 EST 2025 Fri Feb 21 02:44:29 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | Endometriosis Product surveillance, post-marketing Patient-reported outcome measures Dysmenorrhea Quality of life |
| Language | English |
| License | 2022. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c446t-12663d39e68f3f21baef4de1bc31d30f770bb8498a925beeb9af4e6c884e6cde3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0001-6942-3018 |
| OpenAccessLink | https://link.springer.com/10.1007/s12325-022-02301-3 |
| PMID | 36053449 |
| PQID | 2709743038 |
| PQPubID | 23479 |
| PageCount | 18 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9525394 proquest_miscellaneous_2709743038 pubmed_primary_36053449 crossref_citationtrail_10_1007_s12325_022_02301_3 crossref_primary_10_1007_s12325_022_02301_3 springer_journals_10_1007_s12325_022_02301_3 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-11-01 |
| PublicationDateYYYYMMDD | 2022-11-01 |
| PublicationDate_xml | – month: 11 year: 2022 text: 2022-11-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Cheshire |
| PublicationPlace_xml | – name: Cheshire – name: United States |
| PublicationTitle | Advances in therapy |
| PublicationTitleAbbrev | Adv Ther |
| PublicationTitleAlternate | Adv Ther |
| PublicationYear | 2022 |
| Publisher | Springer Healthcare |
| Publisher_xml | – name: Springer Healthcare |
| References | Parasar, Ozcan, Terry (CR7) 2017; 6 Ambacher, Secter, Sanders (CR36) 2022; 38 Momoeda, Akiyama, Tanaka, Suzukamo (CR27) 2020; 12 Bulun, Monsavais, Pavone (CR4) 2012; 30 Fuldeore, Soliman (CR9) 2017; 82 Mehedintu, Plotogea, Ionescu, Antonovici (CR2) 2014; 7 Moos (CR31) 1968; 30 Unsal, Ayranci, Tozun, Arslan, Calik (CR19) 2010; 115 Pitangui, Gomes, Lima, Schwingel, Albuquerque, de Araujo (CR20) 2013; 26 Momoeda, Kondo, Elliesen, Yasuda, Yamamoto, Harada (CR25) 2017; 9 Yamamoto, Ishimori, Sunaya, Watanabe, Sato (CR30) 2020; 41 Alcalde, Martinez-Zamora, Gracia (CR37) 2022; 19 Bulun (CR5) 2009; 360 Harada, Kosaka, Elliesen, Yasuda, Ito, Momoeda (CR29) 2017; 108 El Taha, Abu Musa, Khalifeh, Khalil, Abbasi, Nassif (CR38) 2021; 267 Kawaguchi, Matsumoto, Akira (CR24) 2019; 45 Sukhikh, Adamyan, Dubrovina (CR39) 2021; 116 Wong (CR21) 2018; 15 Eskenazi, Warner (CR8) 1997; 24 Abrao, Surrey, Gordon (CR40) 2021; 21 Janssen, Rijkers, Hoppenbrouwers, Meuleman, D'Hooghe (CR10) 2013; 19 Zondervan, Becker, Missmer (CR12) 2020; 382 Jamieson, Steege (CR16) 1996; 87 Sinaii, Plumb, Cotton (CR6) 2008; 89 Osayande, Mehulic (CR15) 2014; 89 Osuga, Hayashi, Kobayashi (CR23) 2005; 88 Prosperi Porta, Sangiuliano, Cavalli (CR35) 2021; 18 Chapron, Marcellin, Borghese, Santulli (CR1) 2019; 15 Banikarim, Chacko, Kelder (CR18) 2000; 154 Tanaka, Momoeda, Osuga (CR22) 2013; 16 Zhao, Wu, Kang, Wang (CR17) 2021; 12 Harada, Momoeda, Terakawa, Taketani, Hoshiai (CR26) 2011; 95 Norman, Sloan, Wyrwich (CR34) 2003; 41 Greene, Lang, Kendziorski, Sroga-Rios, Herzog, Burns (CR3) 2016; 152 (CR14) 2018; 132 Momoeda, Akiyama, Yamamoto, Kondo, Fukai (CR28) 2020; 12 Gater, Taylor, Seitz, Gerlinger, Wichmann, Haberland (CR32) 2020; 4 Treloar, Bell, Nagle, Purdie, Green (CR11) 2010; 202 Herdman, Gudex, Lloyd (CR33) 2011; 20 Zondervan, Becker, Missmer (CR13) 2020; 382 R Prosperi Porta (2301_CR35) 2021; 18 T Harada (2301_CR26) 2011; 95 SE Bulun (2301_CR4) 2012; 30 M Herdman (2301_CR33) 2011; 20 K Ambacher (2301_CR36) 2022; 38 KT Zondervan (2301_CR13) 2020; 382 N Sinaii (2301_CR6) 2008; 89 M Momoeda (2301_CR25) 2017; 9 MJ Fuldeore (2301_CR9) 2017; 82 AS Osayande (2301_CR15) 2014; 89 M Momoeda (2301_CR27) 2020; 12 P Parasar (2301_CR7) 2017; 6 SE Bulun (2301_CR5) 2009; 360 T Harada (2301_CR29) 2017; 108 S Zhao (2301_CR17) 2021; 12 E Tanaka (2301_CR22) 2013; 16 C Chapron (2301_CR1) 2019; 15 C Banikarim (2301_CR18) 2000; 154 Y Osuga (2301_CR23) 2005; 88 RH Moos (2301_CR31) 1968; 30 GT Sukhikh (2301_CR39) 2021; 116 MS Abrao (2301_CR40) 2021; 21 AC Pitangui (2301_CR20) 2013; 26 L El Taha (2301_CR38) 2021; 267 AM Alcalde (2301_CR37) 2022; 19 A Unsal (2301_CR19) 2010; 115 S Yamamoto (2301_CR30) 2020; 41 EB Janssen (2301_CR10) 2013; 19 GR Norman (2301_CR34) 2003; 41 C Mehedintu (2301_CR2) 2014; 7 SA Treloar (2301_CR11) 2010; 202 M Momoeda (2301_CR28) 2020; 12 AD Greene (2301_CR3) 2016; 152 R Kawaguchi (2301_CR24) 2019; 45 A Gater (2301_CR32) 2020; 4 B Eskenazi (2301_CR8) 1997; 24 CL Wong (2301_CR21) 2018; 15 DJ Jamieson (2301_CR16) 1996; 87 American College of Obstetricians and Gynecologists (ACOG) (2301_CR14) 2018; 132 KT Zondervan (2301_CR12) 2020; 382 |
| References_xml | – volume: 89 start-page: 538 year: 2008 end-page: 545 ident: CR6 article-title: Differences in characteristics among 1000 women with endometriosis based on extent of disease publication-title: Fertil Steril doi: 10.1016/j.fertnstert.2007.03.069 – volume: 30 start-page: 853 year: 1968 end-page: 867 ident: CR31 article-title: The development of a menstrual distress questionnaire publication-title: Psychosom Med doi: 10.1097/00006842-196811000-00006 – volume: 152 start-page: R63 year: 2016 end-page: 78 ident: CR3 article-title: Endometriosis: where are we and where are we going? publication-title: Reproduction doi: 10.1530/REP-16-0052 – volume: 382 start-page: 1244 year: 2020 end-page: 1256 ident: CR13 article-title: Endometriosis publication-title: N Engl J Med doi: 10.1056/NEJMra1810764 – volume: 45 start-page: 766 year: 2019 end-page: 786 ident: CR24 article-title: Guidelines for office gynecology in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2017 edition publication-title: J Obstet Gynaecol Res doi: 10.1111/jog.13831 – volume: 115 start-page: 138 year: 2010 end-page: 145 ident: CR19 article-title: Prevalence of dysmenorrhea and its effect on quality of life among a group of female university students publication-title: Ups J Med Sci doi: 10.3109/03009730903457218 – volume: 9 start-page: 295 year: 2017 end-page: 305 ident: CR25 article-title: Efficacy and safety of a flexible extended regimen of ethinylestradiol/drospirenone for the treatment of dysmenorrhea: a multicenter, randomized, open-label, active-controlled study publication-title: Int J Womens Health doi: 10.2147/IJWH.S134576 – volume: 12 year: 2021 ident: CR17 article-title: Significant increase in depression in women with primary dysmenorrhea: a systematic review and cumulative analysis publication-title: Front Psychiatry doi: 10.3389/fpsyt.2021.686514 – volume: 16 start-page: 1255 year: 2013 end-page: 1266 ident: CR22 article-title: Burden of menstrual symptoms in Japanese women: results from a survey-based study publication-title: J Med Econ doi: 10.3111/13696998.2013.830974 – volume: 132 start-page: e249 year: 2018 end-page: e258 ident: CR14 article-title: ACOG committee opinion no. 760: dysmenorrhea and endometriosis in the adolescent publication-title: Obstet Gynecol doi: 10.1097/AOG.0000000000002978 – volume: 20 start-page: 1727 year: 2011 end-page: 1736 ident: CR33 article-title: Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) publication-title: Qual Life Res doi: 10.1007/s11136-011-9903-x – volume: 26 start-page: 148 year: 2013 end-page: 152 ident: CR20 article-title: Menstruation disturbances: prevalence, characteristics, and effects on the activities of daily living among adolescent girls from Brazil publication-title: J Pediatr Adolesc Gynecol doi: 10.1016/j.jpag.2012.12.001 – volume: 21 start-page: 246 year: 2021 ident: CR40 article-title: Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients publication-title: BMC Womens Health doi: 10.1186/s12905-021-01385-3 – volume: 116 start-page: 1568 year: 2021 end-page: 1577 ident: CR39 article-title: Prolonged cyclical and continuous regimens of dydrogesterone are effective for reducing chronic pelvic pain in women with endometriosis: results of the ORCHIDEA study publication-title: Fertil Steril doi: 10.1016/j.fertnstert.2021.07.1194 – volume: 82 start-page: 453 year: 2017 end-page: 461 ident: CR9 article-title: Prevalence and symptomatic burden of diagnosed endometriosis in the United States: national estimates from a cross-sectional survey of 59,411 women publication-title: Gynecol Obstet Invest doi: 10.1159/000452660 – volume: 7 start-page: 349 year: 2014 end-page: 357 ident: CR2 article-title: Endometriosis still a challenge publication-title: J Med Life – volume: 15 start-page: 80 year: 2018 ident: CR21 article-title: Health-related quality of life among Chinese adolescent girls with dysmenorrhoea publication-title: Reprod Health doi: 10.1186/s12978-018-0540-5 – volume: 38 start-page: 479 issue: 3 year: 2022 end-page: 486 ident: CR36 article-title: The use of progestin subdermal implants in the management of endometriosis-related pain symptoms and quality of life: a systematic review publication-title: Curr Med Res Opin doi: 10.1080/03007995.2022.2031144 – volume: 154 start-page: 1226 year: 2000 end-page: 1229 ident: CR18 article-title: Prevalence and impact of dysmenorrhea on Hispanic female adolescents publication-title: Arch Pediatr Adolesc Med doi: 10.1001/archpedi.154.12.1226 – volume: 87 start-page: 55 year: 1996 end-page: 58 ident: CR16 article-title: The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices publication-title: Obstet Gynecol doi: 10.1016/0029-7844(95)00360-6 – volume: 19 start-page: 570 year: 2013 end-page: 582 ident: CR10 article-title: Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: a systematic review publication-title: Hum Reprod Update doi: 10.1093/humupd/dmt016 – volume: 12 start-page: 175 year: 2020 end-page: 185 ident: CR28 article-title: Burden of menstrual pain measured by heatmap visualization of daily patient-reported data in Japanese patients treated with ethinylestradiol/drospirenone: a randomized controlled study publication-title: Int J Womens Health doi: 10.2147/IJWH.S242864 – volume: 18 start-page: 10602 issue: 20 year: 2021 ident: CR35 article-title: Effects of breastfeeding on endometriosis-related pain: a prospective observational study publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph182010602 – volume: 382 start-page: 1244 year: 2020 end-page: 1256 ident: CR12 article-title: Endometriosis publication-title: N Engl J Med doi: 10.1056/NEJMra1810764 – volume: 19 start-page: 311 year: 2022 end-page: 318 ident: CR37 article-title: Assessment of quality of life, sexual quality of life, and pain symptoms in deep infiltrating endometriosis patients with or without associated adenomyosis and the influence of a flexible extended combined oral contraceptive regimen: results of a prospective, observational study publication-title: J Sex Med doi: 10.1016/j.jsxm.2021.11.015 – volume: 108 start-page: 798 year: 2017 end-page: 805 ident: CR29 article-title: Ethinylestradiol 20 mug/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial publication-title: Fertil Steril doi: 10.1016/j.fertnstert.2017.07.1165 – volume: 89 start-page: 341 year: 2014 end-page: 346 ident: CR15 article-title: Diagnosis and initial management of dysmenorrhea publication-title: Am Fam Physician – volume: 6 start-page: 34 year: 2017 end-page: 41 ident: CR7 article-title: Endometriosis: epidemiology, diagnosis and clinical management publication-title: Curr Obstet Gynecol Rep doi: 10.1007/s13669-017-0187-1 – volume: 88 start-page: 82 year: 2005 end-page: 83 ident: CR23 article-title: Dysmenorrhea in Japanese women publication-title: Int J Gynaecol Obstet doi: 10.1016/j.ijgo.2004.09.004 – volume: 12 start-page: 327 year: 2020 end-page: 338 ident: CR27 article-title: Quality of life in Japanese patients with dysmenorrhea treated with ethinylestradiol 20 mug/drospirenone 3 mg in a real-world setting: an observational study publication-title: Int J Womens Health doi: 10.2147/IJWH.S238460 – volume: 4 start-page: 13 year: 2020 ident: CR32 article-title: Development and content validation of two new patient-reported outcome measures for endometriosis: the Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS) publication-title: J Patient Rep Outcomes doi: 10.1186/s41687-020-0177-3 – volume: 95 start-page: 1928 year: 2011 end-page: 1931 ident: CR26 article-title: Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial publication-title: Fertil Steril doi: 10.1016/j.fertnstert.2011.02.045 – volume: 30 start-page: 39 year: 2012 end-page: 45 ident: CR4 article-title: Role of estrogen receptor-beta in endometriosis publication-title: Semin Reprod Med doi: 10.1055/s-0031-1299596 – volume: 41 start-page: 582 year: 2003 end-page: 592 ident: CR34 article-title: Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation publication-title: Med Care doi: 10.1097/01.MLR.0000062554.74615.4C – volume: 360 start-page: 268 year: 2009 end-page: 279 ident: CR5 article-title: Endometriosis publication-title: N Engl J Med doi: 10.1056/NEJMra0804690 – volume: 24 start-page: 235 year: 1997 end-page: 258 ident: CR8 article-title: Epidemiology of endometriosis publication-title: Obstet Gynecol Clin N Am doi: 10.1016/S0889-8545(05)70302-8 – volume: 41 start-page: 381 year: 2020 end-page: 396 ident: CR30 article-title: Safety and effectiveness of drospirenone/ethinyl estradiol combined tablets for endometriosis-associated pelvic pain and dysmenorrhea in real-world clinical practice: data from post-marketing surveillance in Japan publication-title: Ther Res – volume: 267 start-page: 205 year: 2021 end-page: 212 ident: CR38 article-title: Efficacy of dienogest vs combined oral contraceptive on pain associated with endometriosis: randomized clinical trial publication-title: Eur J Obstet Gynecol Reprod Biol doi: 10.1016/j.ejogrb.2021.10.029 – volume: 15 start-page: 666 year: 2019 end-page: 682 ident: CR1 article-title: Rethinking mechanisms, diagnosis and management of endometriosis publication-title: Nat Rev Endocrinol doi: 10.1038/s41574-019-0245-z – volume: 202 start-page: e1 issue: 534 year: 2010 end-page: 6 ident: CR11 article-title: Early menstrual characteristics associated with subsequent diagnosis of endometriosis publication-title: Am J Obstet Gynecol – volume: 30 start-page: 853 year: 1968 ident: 2301_CR31 publication-title: Psychosom Med doi: 10.1097/00006842-196811000-00006 – volume: 116 start-page: 1568 year: 2021 ident: 2301_CR39 publication-title: Fertil Steril doi: 10.1016/j.fertnstert.2021.07.1194 – volume: 7 start-page: 349 year: 2014 ident: 2301_CR2 publication-title: J Med Life – volume: 115 start-page: 138 year: 2010 ident: 2301_CR19 publication-title: Ups J Med Sci doi: 10.3109/03009730903457218 – volume: 82 start-page: 453 year: 2017 ident: 2301_CR9 publication-title: Gynecol Obstet Invest doi: 10.1159/000452660 – volume: 18 start-page: 10602 issue: 20 year: 2021 ident: 2301_CR35 publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph182010602 – volume: 12 year: 2021 ident: 2301_CR17 publication-title: Front Psychiatry doi: 10.3389/fpsyt.2021.686514 – volume: 12 start-page: 327 year: 2020 ident: 2301_CR27 publication-title: Int J Womens Health doi: 10.2147/IJWH.S238460 – volume: 382 start-page: 1244 year: 2020 ident: 2301_CR12 publication-title: N Engl J Med doi: 10.1056/NEJMra1810764 – volume: 89 start-page: 341 year: 2014 ident: 2301_CR15 publication-title: Am Fam Physician – volume: 6 start-page: 34 year: 2017 ident: 2301_CR7 publication-title: Curr Obstet Gynecol Rep doi: 10.1007/s13669-017-0187-1 – volume: 19 start-page: 570 year: 2013 ident: 2301_CR10 publication-title: Hum Reprod Update doi: 10.1093/humupd/dmt016 – volume: 19 start-page: 311 year: 2022 ident: 2301_CR37 publication-title: J Sex Med doi: 10.1016/j.jsxm.2021.11.015 – volume: 20 start-page: 1727 year: 2011 ident: 2301_CR33 publication-title: Qual Life Res doi: 10.1007/s11136-011-9903-x – volume: 41 start-page: 582 year: 2003 ident: 2301_CR34 publication-title: Med Care doi: 10.1097/01.MLR.0000062554.74615.4C – volume: 21 start-page: 246 year: 2021 ident: 2301_CR40 publication-title: BMC Womens Health doi: 10.1186/s12905-021-01385-3 – volume: 154 start-page: 1226 year: 2000 ident: 2301_CR18 publication-title: Arch Pediatr Adolesc Med doi: 10.1001/archpedi.154.12.1226 – volume: 267 start-page: 205 year: 2021 ident: 2301_CR38 publication-title: Eur J Obstet Gynecol Reprod Biol doi: 10.1016/j.ejogrb.2021.10.029 – volume: 202 start-page: e1 issue: 534 year: 2010 ident: 2301_CR11 publication-title: Am J Obstet Gynecol – volume: 9 start-page: 295 year: 2017 ident: 2301_CR25 publication-title: Int J Womens Health doi: 10.2147/IJWH.S134576 – volume: 15 start-page: 666 year: 2019 ident: 2301_CR1 publication-title: Nat Rev Endocrinol doi: 10.1038/s41574-019-0245-z – volume: 95 start-page: 1928 year: 2011 ident: 2301_CR26 publication-title: Fertil Steril doi: 10.1016/j.fertnstert.2011.02.045 – volume: 30 start-page: 39 year: 2012 ident: 2301_CR4 publication-title: Semin Reprod Med doi: 10.1055/s-0031-1299596 – volume: 26 start-page: 148 year: 2013 ident: 2301_CR20 publication-title: J Pediatr Adolesc Gynecol doi: 10.1016/j.jpag.2012.12.001 – volume: 45 start-page: 766 year: 2019 ident: 2301_CR24 publication-title: J Obstet Gynaecol Res doi: 10.1111/jog.13831 – volume: 360 start-page: 268 year: 2009 ident: 2301_CR5 publication-title: N Engl J Med doi: 10.1056/NEJMra0804690 – volume: 87 start-page: 55 year: 1996 ident: 2301_CR16 publication-title: Obstet Gynecol doi: 10.1016/0029-7844(95)00360-6 – volume: 15 start-page: 80 year: 2018 ident: 2301_CR21 publication-title: Reprod Health doi: 10.1186/s12978-018-0540-5 – volume: 4 start-page: 13 year: 2020 ident: 2301_CR32 publication-title: J Patient Rep Outcomes doi: 10.1186/s41687-020-0177-3 – volume: 382 start-page: 1244 year: 2020 ident: 2301_CR13 publication-title: N Engl J Med doi: 10.1056/NEJMra1810764 – volume: 108 start-page: 798 year: 2017 ident: 2301_CR29 publication-title: Fertil Steril doi: 10.1016/j.fertnstert.2017.07.1165 – volume: 152 start-page: R63 year: 2016 ident: 2301_CR3 publication-title: Reproduction doi: 10.1530/REP-16-0052 – volume: 88 start-page: 82 year: 2005 ident: 2301_CR23 publication-title: Int J Gynaecol Obstet doi: 10.1016/j.ijgo.2004.09.004 – volume: 132 start-page: e249 year: 2018 ident: 2301_CR14 publication-title: Obstet Gynecol doi: 10.1097/AOG.0000000000002978 – volume: 16 start-page: 1255 year: 2013 ident: 2301_CR22 publication-title: J Med Econ doi: 10.3111/13696998.2013.830974 – volume: 38 start-page: 479 issue: 3 year: 2022 ident: 2301_CR36 publication-title: Curr Med Res Opin doi: 10.1080/03007995.2022.2031144 – volume: 12 start-page: 175 year: 2020 ident: 2301_CR28 publication-title: Int J Womens Health doi: 10.2147/IJWH.S242864 – volume: 41 start-page: 381 year: 2020 ident: 2301_CR30 publication-title: Ther Res – volume: 24 start-page: 235 year: 1997 ident: 2301_CR8 publication-title: Obstet Gynecol Clin N Am doi: 10.1016/S0889-8545(05)70302-8 – volume: 89 start-page: 538 year: 2008 ident: 2301_CR6 publication-title: Fertil Steril doi: 10.1016/j.fertnstert.2007.03.069 |
| SSID | ssj0020758 |
| Score | 2.34482 |
| Snippet | Introduction
Dysmenorrhea and endometriosis are common gynecologic disorders among women of reproductive age that significantly impact health-related quality... Dysmenorrhea and endometriosis are common gynecologic disorders among women of reproductive age that significantly impact health-related quality of life (HRQL)... |
| SourceID | pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 5087 |
| SubjectTerms | Adult Androstenes Cardiology Dysmenorrhea - complications Dysmenorrhea - etiology Endocrinology Endometriosis - complications Endometriosis - drug therapy Female Humans Internal Medicine Japan Medicine Medicine & Public Health NCT NCT03126747 Oncology Original Research Pelvic Pain - drug therapy Pelvic Pain - etiology Pharmacology/Toxicology Quality of Life Rheumatology |
| Title | Quality of Life in Japanese Patients with Dysmenorrhea or Endometriosis-Associated Pelvic Pain Treated with Extended Regimen Ethinylestradiol/Drospirenone in a Real-World Setting: A Prospective Observational Study |
| URI | https://link.springer.com/article/10.1007/s12325-022-02301-3 https://www.ncbi.nlm.nih.gov/pubmed/36053449 https://www.proquest.com/docview/2709743038 https://pubmed.ncbi.nlm.nih.gov/PMC9525394 |
| Volume | 39 |
| WOSCitedRecordID | wos000849172800003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAVX databaseName: SpringerLink Contemporary customDbUrl: eissn: 1865-8652 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0020758 issn: 0741-238X databaseCode: RSV dateStart: 20000101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZoQYgLj_IKj2qQUC9sxCZ2Ngm3im6FUClRu1R7i-LYhkghQckWKT-U_8OMk-xqKaoElxySsePE43nYM98w9lqjYFRoSaOTI3JXKB-XVJDlrgmUVDkKTc9CKV2chKen0XIZJ0NSWDtGu49HklZSb5LdUPlTNrHvkt3suXyH3UR1F1HBhrPzi7WbhUow6sE3PRcV0nJIlfl7H9vq6IqNeTVU8o_zUquGju_93wfcZ3cHsxMOez55wG7oao_d_jQcrO-xg6SHsO4msNhkZLUTOIBkA27dPWS_etCNDmoDJ4XRUFTwERUuFbKEpAdpbYF2d-GoI8TPumlQ3kPdwLxS9Xcq4FW3ReuOfKEVJLpEeYWtsa8FGbF4z_YwH3bo4Ux_pSoEQNH5VVdq2p9RRV2-PWqo7kmDr6nsUDIkzUrXhgjBubZB3e_gEBKi62U7fJbrnWj8JRRI2T1iX47ni_cf3KE0hJuj_7pyPbQruOKxnkWGG9-TmTZCaU_m3FN8asJwKmUk4iiL_UBqLePMCD3Lo4iuSvPHbJdG9pSBNJznIQq6jAdC6FAaj6wyJaTJcj1TDvNGDknzATedyneU6QbxmSY2xYlN7cSm3GFv1m1-9Kgh11K_GhkvxcVNJzY4a_Vlm_rhFP09tDIihz3pGXHdH0dHlAsROyzcYtE1AQGHbz-pim8WQDwO_IDHwmGTkVHTQXK11wzz2b-RP2d3fOJ1m7f5gu2umkv9kt3Kf66KttlnO-Ey2rcL9zdVZUI2 |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgIOCFj_FVPg8J7YVGNLHTJLxNrNOArkRbmfoWxbENkUqCkg4pfyj_D3dO0qoMTYKXPCRnx4nP92Hf_Y6x1xoFo0JLGp0ckTlCebik_DRzjK-kylBouhZK6WwazGbhYhHFXVJY3Ue790eSVlJvkt1Q-VM2seeQ3ew6_Cq7JlBjEWL-yenZ2s1CJRi24Juugwpp0aXK_L2PbXV0wca8GCr5x3mpVUOHd_7vA-6y253ZCfstn9xjV3Sxy24cdwfru2wvbiGsmyHMNxlZ9RD2IN6AWzf32a8WdKOB0sA0NxryAj6iwqVClhC3IK010O4uHDSE-FlWFcp7KCuYFKr8TgW8yjqvnZ4vtIJYL1FeYWvsa05GLN6zPUy6HXo40V-pCgFQdH7RLDXtz6i8XL49qKjuSYWvKexQUiRNl44NEYJTbYO638E-xETXynb4LNc70fhLKJCyecC-HE7m74-crjSEk6H_unJctCu44pEeh4Ybz5WpNkJpV2bcVXxkgmAkZSiiMI08X2oto9QIPc7CkK5K84dsh0b2mIE0nGcBCrqU-0LoQBqXrDIlpEkzPVYD5vYckmQdbjqV71gmG8RnmtgEJzaxE5vwAXuzbvOjRQ25lPpVz3gJLm46scFZK8_rxAtG6O-hlREO2KOWEdf9cXREuRDRgAVbLLomIODw7SdF_s0CiEe-5_NIDNiwZ9Skk1z1JcN88m_kL9nNo_nxNJl-mH16ym55xPc2h_MZ21lV5_o5u579XOV19cIu39_eCkQy |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELZgQSsuPJZXeQ4S2gsbtYmdJuG2oq14lBKxZdVbFMc2RCrJKuki5Yfyf5hx0payaCXEpYd24rr1eOYbe-Ybxl5qNIwKkTQGOSJzhPJwS_lp5hhfSZWh0XQtldLpNJjNwsUiin-r4rfZ7usrybamgViailX_TJn-tvANgQBVFnsOYWjX4VfZNUGJ9BSvn5xuQi50iGFLxOk66JwWXdnM38fYdU0X8ObFtMk_7k6tS5rc-v8fc5vd7OAoHLf6c4dd0cUB2__YXbgfsMO4pbZujmC-rdSqj-AQ4i3pdXOX_WzJOBooDUxzoyEv4D06YmpwCXFL3loDnfrCqCEm0LKq0A9AWcG4UOV3auxV1nntrPVFK4j1Eu0YPo1jzQnc4nt2hHF3cg-f9VfqTgCUtV80S03nNiovl_1RRf1QKvyawk4lRdF06djUITjRNtn7NRxDTHKtzYdPcnNCjX8JJVg299iXyXj-5q3TtYxwMoxrV46LeIMrHulhaLjxXJlqI5R2ZcZdxQcmCAZShiIK08jzpdYySo3QwywM6VVpfp_t0cweMpCG8yxAA5hyXwgdSOMSWlNCmjTTQ9Vj7lpbkqzjU6e2HstkywRNC5vgwiZ2YRPeY682z5y1bCKXSr9YK2GCm55ucnDVyvM68YIBxoGIPsIee9Aq5WY8jgEqFyLqsWBHXTcCRCi--0mRf7PE4pHv-TwSPXa0Vtqks2j1JdN89G_iz9l-PJok03ezD4_ZDY_U3pZ2PmF7q-pcP2XXsx-rvK6e2Z38C-rOTRY |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quality+of+Life+in+Japanese+Patients+with+Dysmenorrhea+or+Endometriosis-Associated+Pelvic+Pain+Treated+with+Extended+Regimen+Ethinylestradiol%2FDrospirenone+in+a+Real-World+Setting%3A+A+Prospective+Observational+Study&rft.jtitle=Advances+in+therapy&rft.au=Yoshino%2C+Osamu&rft.au=Suzukamo%2C+Yoshimi&rft.au=Yoshihara%2C+Keisuke&rft.au=Takahashi%2C+Noriko&rft.date=2022-11-01&rft.pub=Springer+Healthcare&rft.issn=0741-238X&rft.eissn=1865-8652&rft.volume=39&rft.issue=11&rft.spage=5087&rft.epage=5104&rft_id=info:doi/10.1007%2Fs12325-022-02301-3&rft.externalDocID=10_1007_s12325_022_02301_3 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0741-238X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0741-238X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0741-238X&client=summon |